Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06207656
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-12-27
Brief Title:
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization Data
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Class:
OTHER
Study ID:
TTD-21-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck SL Spain | INDUSTRY |
| Pierre Fabre Ibérica SA | INDUSTRY |